<DOC>
	<DOCNO>NCT01473290</DOCNO>
	<brief_summary>RATIONALE : Probiotic therapy may reduce prevent gastrointestinal complication patient undergo chemotherapy pelvic radiation therapy . PURPOSE : This randomized phase III trial study well probiotic therapy work prevent gastrointestinal complication patient undergo chemotherapy pelvic radiation therapy .</brief_summary>
	<brief_title>Probiotic Therapy Preventing Gastrointestinal Complications Patients Undergoing Chemotherapy Pelvic Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine whether live freeze-dried lactic acid bacteria probiotic ( VSL # 3® ) effective reduce acute treatment-related bowel function disturbance , measure FACIT-D diarrhea subscale score patient receive concurrent chemotherapy pelvic RT adjuvant primary treatment malignancy . Secondary - To determine whether VSL # 3® reduce chronic treatment-related bowel dysfunction follow completion therapy . - To examine whether VSL # 3® appear impact disease-free survival . - To bank blood product future study . ( exploratory ) - To characterize change fecal microbiota examine correlation treatment assignment symptom score . ( exploratory ) OUTLINE : This randomize , double-blind , placebo-controlled study . Patients stratify accord site primary tumor ( rectum/anus v ) , history anterior resection rectum ( yes v ) , total plan cumulative dose ( include boost external-beam radiotherapy [ RT ] brachytherapy ) ( 4,500-5,350 cGy v &gt; 5,350 cGy ) , use intensity-modulated RT [ IMRT ] pelvic RT ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive live freeze-dried lactic acid bacteria probiotic ( VSL # 3® ) orally ( PO ) 3 time day RT ( 5-8 week ) 2 week completion RT . - Arm II : Patients receive placebo PO 3 time day RT ( 5-8 week ) 2 week completion RT . Patients self-report symptom use FACIT-D , PBFQ , PRO-CTCAE , Uniscale/fatigue weekly RT , 2 week completion RT , 12 month follow completion RT . Blood stool sample may collect patient correlative study .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Intestinal Obstruction</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Current diagnosis cancer support use continuous definitive adjuvant externalbeam radiotherapy ( RT ) pelvis minimum dose 4,500 cGy follow parameter : The pelvis must encompass plan RT field The superior border may lie inferior inferior aspect sacroiliac joint Portions rectum may special blocking , depend upon disease site The total prescription dose must lie 4,5005,350 cGy ( inclusive ) A boost primary tumor tumor bed may plan Planned treatment give 45 time per week one treatmentperday basis The daily prescribe dose must lie 170210 cGy ( inclusive ) per day No plan splitcourse RT No proton RT Will receive concurrent administration chemotherapy ( fluorouracil , capecitabine , cisplatin , oxaliplatin , carboplatin , and/or mitomycin C ) pelvic RT No current prior metastases beyond regional lymph node PATIENT CHARACTERISTICS : ECOG performance status ( PS ) 0 , 1 , 2 Life expectancy ≥ 6 month Able complete questionnaire ( ) assistance Not pregnant nursing Negative pregnancy test do ≤ 7 day prior registration , woman childbearing potential Fertile patient must use effective contraception Hemoglobin &gt; 10.0 g/dL White blood cell ( WBC ) &gt; 3,500/mm³ Absolute neutrophil count ( ANC ) &gt; 1,500/mm³ Platelet count &gt; 100,000/mm³ Willing abstain ingestion yogurt product and/or product contain probiotic study drug treatment No known allergy probiotic preparation No history inflammatory bowel disease No ≥ grade 3 diarrhea , ≥ grade 3 rectal bleeding , abdominal cramping , incontinence stool ≤ 7 day prior registration No medical condition may interfere ability receive protocol treatment No history gastrointestinal genitourinary obstruction porphyria No history irritable bowel syndrome ( IBS ) PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior abdominalperineal resection , Hartmann procedure , surgical procedure leave patient without function rectum No plan use leucovorin No prior pelvic RT No use probiotic ≤ 2 week prior registration No use antibiotic ≤ 3 day prior registration No plan continuous antibiotic treatment RT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>diarrhea</keyword>
	<keyword>constipation , impaction , bowel obstruction</keyword>
	<keyword>gastrointestinal complication</keyword>
	<keyword>fatigue</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>